Annual Short Term Debt
$27.97 M
+$14.18 M+102.88%
31 December 2023
Summary:
Cytokinetics Incorporated annual short term debt is currently $27.97 million, with the most recent change of +$14.18 million (+102.88%) on 31 December 2023. During the last 3 years, it has risen by +$25.19 million (+904.34%). CYTK annual short term debt is now at all-time high.CYTK Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$30.38 M
+$349.00 K+1.16%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly short term debt is currently $30.38 million, with the most recent change of +$349.00 thousand (+1.16%) on 30 September 2024. Over the past year, it has increased by +$13.14 million (+76.24%). CYTK quarterly short term debt is now -0.28% below its all-time high of $30.46 million, reached on 30 September 2021.CYTK Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +102.9% | +76.2% |
3 y3 years | +904.3% | -0.3% |
5 y5 years | +972.9% | +563.7% |
CYTK Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +904.3% | -0.3% | +120.3% |
5 y | 5 years | at high | +972.9% | -0.3% | +990.7% |
alltime | all time | at high | >+9999.0% | -0.3% | >+9999.0% |
Cytokinetics Incorporated Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $30.38 M(+1.2%) |
June 2024 | - | $30.03 M(+0.9%) |
Mar 2024 | - | $29.75 M(+6.4%) |
Dec 2023 | $27.97 M(+102.9%) | $27.97 M(+62.3%) |
Sept 2023 | - | $17.24 M(+9.8%) |
June 2023 | - | $15.70 M(+10.1%) |
Mar 2023 | - | $14.26 M(+3.5%) |
Dec 2022 | $13.79 M(-7.2%) | $13.79 M(-14.1%) |
Sept 2022 | - | $16.06 M(+12.3%) |
June 2022 | - | $14.30 M(-1.3%) |
Mar 2022 | - | $14.49 M(-2.5%) |
Dec 2021 | $14.86 M(+433.7%) | $14.86 M(-51.2%) |
Sept 2021 | - | $30.46 M(+30.0%) |
June 2021 | - | $23.44 M(+114.7%) |
Mar 2021 | - | $10.92 M(+292.1%) |
Dec 2020 | $2.79 M(-39.7%) | $2.79 M(-29.4%) |
Sept 2020 | - | $3.94 M(-22.3%) |
June 2020 | - | $5.08 M(+0.9%) |
Mar 2020 | - | $5.03 M(+9.0%) |
Dec 2019 | $4.62 M(+77.1%) | $4.62 M(+0.9%) |
Sept 2019 | - | $4.58 M(+0.9%) |
June 2019 | - | $4.54 M(-57.6%) |
Mar 2019 | - | $10.71 M(+310.9%) |
Dec 2018 | $2.61 M(+4.3%) | $2.61 M(-31.0%) |
Sept 2018 | - | $3.78 M(+121.8%) |
June 2018 | - | $1.70 M(-82.7%) |
Sept 2017 | - | $9.83 M(+34.4%) |
June 2017 | - | $7.32 M(+51.6%) |
Mar 2017 | - | $4.83 M(+93.0%) |
Dec 2016 | $2.50 M(+1544.7%) | $2.50 M(+1544.7%) |
Dec 2011 | $152.00 K | $152.00 K(-51.0%) |
Sept 2011 | - | $310.00 K(-36.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2011 | - | $489.00 K(-29.1%) |
Mar 2011 | - | $690.00 K(-17.2%) |
Dec 2010 | $833.00 K(-93.0%) | $833.00 K(-19.0%) |
Sept 2010 | - | $1.03 M(-18.9%) |
June 2010 | - | $1.27 M(-88.8%) |
Mar 2010 | - | $11.33 M(-4.2%) |
Dec 2009 | $11.82 M(+483.6%) | $11.82 M(+585.0%) |
Sept 2009 | - | $1.73 M(-87.8%) |
June 2009 | - | $14.08 M(+631.6%) |
Mar 2009 | - | $1.93 M(-4.9%) |
Dec 2008 | $2.02 M(-50.0%) | $2.02 M(-17.7%) |
Sept 2008 | - | $2.46 M(-18.8%) |
June 2008 | - | $3.03 M(-14.5%) |
Mar 2008 | - | $3.54 M(-12.5%) |
Dec 2007 | $4.05 M(+9.7%) | $4.05 M(-2.9%) |
Sept 2007 | - | $4.17 M(+1.3%) |
June 2007 | - | $4.12 M(+1.9%) |
Mar 2007 | - | $4.04 M(+9.4%) |
Dec 2006 | $3.69 M(+35.4%) | $3.69 M(+11.3%) |
Sept 2006 | - | $3.32 M(+10.9%) |
June 2006 | - | $2.99 M(+8.2%) |
Mar 2006 | - | $2.76 M(+1.4%) |
Dec 2005 | $2.73 M(+14.2%) | $2.73 M(+4.5%) |
Sept 2005 | - | $2.61 M(+6.5%) |
June 2005 | - | $2.45 M(+1.1%) |
Mar 2005 | - | $2.42 M(+1.4%) |
Dec 2004 | $2.39 M(+18.9%) | $2.39 M(+11.0%) |
Sept 2004 | - | $2.15 M(+2.0%) |
June 2004 | - | $2.11 M(+5.8%) |
Mar 2004 | - | $1.99 M(-0.8%) |
Dec 2003 | $2.01 M(-16.9%) | $2.01 M |
Dec 2002 | $2.42 M | - |
FAQ
- What is Cytokinetics Incorporated annual short term debt?
- What is the all time high annual short term debt for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual short term debt year-on-year change?
- What is Cytokinetics Incorporated quarterly short term debt?
- What is the all time high quarterly short term debt for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly short term debt year-on-year change?
What is Cytokinetics Incorporated annual short term debt?
The current annual short term debt of CYTK is $27.97 M
What is the all time high annual short term debt for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual short term debt is $27.97 M
What is Cytokinetics Incorporated annual short term debt year-on-year change?
Over the past year, CYTK annual short term debt has changed by +$14.18 M (+102.88%)
What is Cytokinetics Incorporated quarterly short term debt?
The current quarterly short term debt of CYTK is $30.38 M
What is the all time high quarterly short term debt for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly short term debt is $30.46 M
What is Cytokinetics Incorporated quarterly short term debt year-on-year change?
Over the past year, CYTK quarterly short term debt has changed by +$13.14 M (+76.24%)